Compounded medication — not FDA-approved
This article discusses compounded medications that are not FDA-approved products. Compounded medications are prepared by licensed 503A/503B pharmacies based on a licensed provider's prescription. They are not evaluated by the FDA for safety or efficacy. Nothing in this article constitutes medical advice, diagnosis, or a recommendation to use any product. All prescribing and dosing decisions are made by a licensed physician during intake.
What NAD+ Actually Does
Nicotinamide adenine dinucleotide — NAD+ for short — is a coenzyme present in every cell of your body. It's not a hormone or a signaling molecule in the usual sense. It's a metabolic currency. Hundreds of enzymes require NAD+ to function, and the cellular processes those enzymes run include energy production, DNA repair, inflammation regulation, and circadian rhythm control.
The most-discussed NAD+-dependent enzymes are the sirtuins — SIRT1 through SIRT7. These are sometimes called the 'longevity genes' because they appear to be the enzymes that implement the lifespan-extending effects of caloric restriction, exercise, and fasting. All seven sirtuins require NAD+ to function. When NAD+ runs low, sirtuin activity drops.
Another set of enzymes called PARPs also burn through NAD+ — their job is fixing damaged DNA. PARPs repair DNA damage — a critical function, especially in tissues exposed to oxidative stress, UV, or chemotherapeutic agents. Like sirtuins, PARPs run out of function when NAD+ supplies drop.
Why Oral NAD+ Supplements Underperform
The supplement industry has responded to NAD+ research with a flood of oral products — NAD+, nicotinamide mononucleotide (NMN), and nicotinamide riboside (NR) capsules. The logic seems sound: take an NAD+ precursor orally, your body converts it to NAD+, your cells get more NAD+.
The reality is more complicated. Direct oral NAD+ has very poor bioavailability — your gut breaks the molecule apart before it can get into your blood. Studies estimate less than 5 percent of an oral NAD+ dose reaches the bloodstream intact.
Oral NMN and NR improve on this substantially. NR in particular has good oral bioavailability and does raise blood NAD+ levels measurably.[1] But here's the catch: raising blood NAD+ is not the same as raising tissue NAD+, and the tissues that matter most for longevity — brain, heart, muscle — appear to be relatively resistant to getting NAD+ from circulating supply. NMN may have slightly better tissue uptake than NR, but the human data is still evolving.
Most published human studies on oral NR have shown modest effects on blood NAD+ and inconsistent effects on downstream biomarkers. Some studies show improvements in biomarkers of aging; others show no effect. This is not the picture you'd expect from a supplement that's genuinely restoring NAD+ to youthful levels.
Key Takeaway
Sources & references
- [1]Martens CR, et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications, 2018. ↩
Injectable NAD+: The Bioavailability Argument
Injectable NAD+ bypasses the GI absorption problem entirely. A subcutaneous or intramuscular injection of NAD+ delivers the molecule directly into the tissue and bloodstream, where it's taken up by cells through the normal channels cells use to bring it in.
The practical effect is that injectable NAD+ produces a much larger rise in measurable NAD+ than any oral protocol, and the effect reaches tissues that oral precursors struggle to affect. The tradeoff is that it's a prescription medication rather than an OTC supplement, and it requires injection — usually subcutaneous, similar to how insulin is administered.
Clinical NAD+ protocols are widely used by longevity physicians and anti-aging clinics. The original high-dose protocol — NAD+ IV infusion at 500-1,000mg over several hours — is still used for specific indications (post-addiction recovery, severe neurological conditions) but is logistically difficult and expensive. The subcutaneous injection protocol, at doses of 100-300mg once or twice weekly, has become the standard for biohacker and longevity use. It's cheaper, can be self-administered at home, and produces consistent effects.
What Patients Report
The most common reports from patients starting injectable NAD+ protocols:
Increased energy. Many patients report the effect is subtle at first and then becomes more apparent after they take a break from the protocol and notice how much energy they had while on it. Individual timelines vary.
Improved focus and mental stamina. Patients working demanding cognitive schedules — executives, physicians, researchers — frequently report this is the most noticeable benefit.
Better exercise recovery. Muscle soreness tends to resolve faster and workout capacity tends to improve. This is consistent with NAD+'s role in muscle mitochondrial function.
Better sleep quality. Not universal, but commonly reported. This is harder to attribute because sleep is affected by so many variables.
What patients don't typically report: a dramatic transformation. NAD+ replacement is not a stimulant or a mood-altering drug. The effects build gradually and are noticed mostly in comparison to how the patient felt before. Individual response is assessed with your prescribing provider.
Dosing, Frequency, and Stacking
Specific dosing, frequency, and administration are determined by the prescribing provider based on the patient's health history, bloodwork, and clinical goals. Published research describes a range of approaches, but the protocol for any individual patient is a clinical decision made during intake.
Injectable NAD+ is typically administered subcutaneously. Periodic blood markers (not specifically for NAD+ levels, but for general metabolic health) and physician follow-up are standard components of a supervised protocol.
NAD+ stacks well with other longevity interventions. The most common pairings in published protocols:
- Rapamycin for the autophagy/mTOR side of longevity - Sermorelin or Tesamorelin for GH axis support - Metformin for insulin sensitivity (though this is an unsettled stack question) - Exercise, especially zone 2 which itself raises NAD+ levels
Some patients stack oral NMN or NR with injectable NAD+ on non-injection days for continuous support. Whether this adds meaningful benefit beyond the injectable alone is not clearly established, but the cost is low and the downside is minimal.
Safety and Side Effects
Injectable NAD+ at longevity doses has a strong safety profile. The most common side effects are injection site reactions (redness, minor soreness) and occasional flushing during the first few minutes after injection. Some patients report transient nausea or a sense of chest pressure with rapid administration — this is why subcutaneous (slower absorption) is preferred over IV for outpatient use.
At IV doses above 500mg given over less than an hour, patients can experience more pronounced flushing and cardiovascular effects. This is why the classic IV NAD+ protocols are given over 4-8 hours, not as a single fast dose. The subcutaneous protocol at 100-300mg essentially never produces these effects because the absorption is gradual.
Contraindications are limited. Pregnancy and nursing are the main ones. Patients with serious kidney or liver problems should discuss with their physician. Patients on chemotherapy should coordinate with their oncologist, as the interaction between NAD+ and certain chemotherapy agents is an active area of research.
Getting NAD+ Prescribed
Injectable NAD+ is compounded by 503A pharmacies and requires a physician prescription. Most primary care physicians are not familiar with longevity-focused NAD+ protocols, so patients typically access it through:
- Telehealth platforms that specialize in longevity protocols - Age management or functional medicine clinics - Direct-pay longevity physicians (e.g., members of the Peter Attia style concierge practices)
The telehealth route has become the dominant access path because it's accessible regardless of geography and because the physicians on these platforms actually run the protocols rather than learning them from the patient. A standard intake includes medical history, current medications, goals, and sometimes baseline bloodwork. Prescriptions are fulfilled by a partnered compounding pharmacy and shipped directly to the patient.
For patients serious about longevity, NAD+ is one of the foundational interventions. It's well-studied, its age-related decline is well-documented, and injectable delivery solves the bioavailability problems that limit oral supplementation. It's not a substitute for the basics of good health, but for patients already doing the basics, NAD+ is one of the clearest incremental levers available.
Editorial & medical disclaimer
This article is published by the Pepvio editorial team for informational purposes only. It is not medical advice, diagnosis, or treatment, and it has not been reviewed by a licensed clinician. The information presented draws on published research but should not substitute for professional medical guidance. Pepvio protocols require a prescription from a licensed healthcare provider. Individual results vary. Always consult your physician before starting any new treatment protocol. Pepvio does not claim that any product cures, treats, or prevents any disease.
Ready to explore peptide-anchored biohacking?
Take our 2-minute health assessment to see which Pepvio protocol fits your goals. A licensed provider reviews every response.
Find My ProtocolKeep reading
Rapamycin: The Drug Bryan Johnson and Peter Attia Actually Take
Rapamycin (sirolimus) has extended median lifespan in every mammalian species tested. It's the longevity drug Bryan Johnson, Peter Attia, and an expanding cohort of physicians take personally. Here's what the research shows, how it's dosed for longevity, and who should and shouldn't consider it.
Read articleMetformin for Longevity: Why Peter Attia Reconsidered His Position
Peter Attia publicly backed off metformin as a longevity recommendation around 2022-2023, citing research on mitochondrial adaptations to exercise. Here's the full arc — the original rationale, the specific findings that changed his mind, the TAME trial context, and where other longevity clinicians have landed. An authority-content read for anyone tracking the metformin-longevity debate.
Read articleWhat Are Peptides? A Complete Guide for 2026
Peptides are short chains of amino acids that act as signaling molecules in the body. Learn how peptide therapy works, the types of peptides available, safety considerations, and what changed with the 2026 FDA reclassification.
Read article